라이엘 이뮤노파마
LYEL · 최근 20건
11
매수
9
매도
+$804K
순매수
거래 내역
Bulis Veronica Sanchez
VP, Corporate Controller · 2026. 8. 10.
−$9K
매도
Seely Lynn
President and CEO · 2026. 8. 10.
−$6K
매도
Hill Stephen J.
Chief Operating Officer · 2026. 8. 10.
−$1K
매도
Lee Gary K.
Chief Scientific Officer · 2026. 8. 10.
−$2K
매도
Innovative Cellular Therapeutics Holdings Ltd
10% Owner · 2026. 7. 27.
+
매수
Innovative Cellular Therapeutics Holdings Ltd
10% Owner · 2026. 7. 27.
+
매수
Innovative Cellular Therapeutics Holdings Ltd
10% Owner · 2026. 7. 17.
−$137
매도
Innovative Cellular Therapeutics Holdings Ltd
10% Owner · 2026. 7. 16.
−$137
매도
Innovative Cellular Therapeutics Holdings Ltd
10% Owner · 2026. 6. 29.
+
매수
Innovative Cellular Therapeutics Holdings Ltd
10% Owner · 2026. 6. 15.
+
매수
Shook David
Chief Medical Officer · 2026. 6. 10.
−$25K
매도
Bachleda Mark
Director · 2026. 6. 10.
+$122K
매수
NABEL ELIZABETH G
Director · 2026. 6. 10.
+$122K
매수
Klausner Richard
Director · 2026. 6. 10.
+$122K
매수
Ramachandra Sumant
Director · 2026. 6. 10.
+$122K
매수
FRIEDMAN CATHY
Director · 2026. 6. 10.
+$122K
매수
BRAWLEY OTIS W
Director · 2026. 6. 10.
+$122K
매수
RIEFLIN WILLIAM JL
Director · 2026. 6. 10.
+$122K
매수
Seely Lynn
President and CEO · 2026. 5. 11.
−$7K
매도
Hill Stephen J.
Chief Operating Officer · 2026. 5. 11.
−$2K
매도